继发进展型多发性硬化患者MRI缓慢扩展病灶与残疾的关联
本研究回顾性分析MS-SMART试验中345例继发进展型多发性硬化(SPMS)患者,在基线及第24、96周行脑MRI,评估缓慢扩展病灶(SEL)与残疾的关系。结果显示约29%的T2病灶为明确SEL,SEL体积较大与残疾评分恶化及残疾进展风险升高相关。
要点
- SPMS患者中约29%的T2病灶为明确SEL。
- 明确SEL体积较大与基线T2病灶体积较高及脑容量下降相关。
- 明确SEL体积较大与残疾加重及残疾进展风险升高相关。
核心结论
- 明确SEL约占SPMS患者T2病灶的三分之一,与神经退行性MRI标志物相关并和临床恶化相关,作者认为其可能参与疾病进展并成为治疗干预的新靶点。
研究设计与样本
- 回顾性研究,纳入MS-SMART试验中345例SPMS患者,在基线及第24、96周行脑MRI。
- 明确SEL定义为经非线性形变容积T1加权图像评估的同心性扩展T2病灶。
- 采用Pearson相关和回归分析评估SEL体积与其他MRI指标及残疾的关联。
主要发现
- 患者平均有29%的T2病灶被分类为明确SEL。
- 明确SEL体积较大与基线总T2病灶体积较高相关(r=0.55,p<0.001),与脑体积下降百分比较高相关(r=-0.26,p<0.001),与新增持续存在的T1黑洞数量较多相关(r=0.19,p<0.001)。
- 在106例患者的亚组中,明确SEL体积较大与磁化传递率下降较多相关(校正后差值0.52,p<0.001)。
- 回归分析中,明确SEL体积较高与扩展残疾状态量表评分升高相关(β=0.23,p=0.020),与多发性硬化功能复合评分z评分降低相关(β=-0.47,p=0.048),与定时25英尺步行测试结果降低相关(β=-2.10,p=0.001),与节律性听觉序列加法任务评分降低相关(β=-0.27,p=0.006),并与残疾进展风险升高相关(比值比1.92,p=0.025)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND AND OBJECTIVE: To explore the relationship between slowly expanding lesions (SELs) on MRI and disability in secondary progressive multiple sclerosis (SPMS). METHODS: We retrospectively studied 345 patients with SPMS enrolled in the MS-SMART trial. They underwent brain MRI at baseline and at 24 and 96 weeks. Definite SELs were defined as concentrically expanding T2 lesions, as assessed by nonlinear deformation of volumetric T1-weighted images. Associations of SEL volumes with other MRI metrics and disability were assessed through Pearson correlations and regression analyses. RESULTS: Averaged across patients, 29% of T2 lesions were classified as being definite SELs. A greater volume of definite SELs correlated with a higher total baseline T2 lesion volume (r = 0.55, p < 0.001) and percentage brain volume reduction (r = -0.26, p < 0.001), a higher number of new persisting T1 black holes (r = 0.19, p < 0.001), and, in a subset of 106 patients, with a greater reduction in magnetization transfer ratio (adjusted difference 0.52, p < 0.001). In regression analyses, a higher definite SEL volume was associated with increasing disability, as assessed by the Expanded Disability Status Scale (β = 0.23, p = 0.020), z scores of the Multiple Sclerosis Functional Composite (β = -0.47, p = 0.048), Timed 25-Foot Walk Test (β = -2.10, p = 0.001), and Paced Auditory Serial Addition Task (β = -0.27, p = 0.006), and increased risk of disability progression (odds ratio 1.92, p = 0.025). DISCUSSION: Definite SELs represent almost one-third of T2 lesions in SPMS. They are associated with neurodegenerative MRI markers and related to clinical worsening, suggesting that they may contribute to disease progression and be a new target for therapeutic interventions.
引用
- Calvi A, Carrasco FP, Tur C, et al. Association of Slowly Expanding Lesions on MRI With Disability in People With Secondary Progressive Multiple Sclerosis. Neurology. 2022. PMID: 35277438. doi:10.1212/WNL.0000000000200144
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。